Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease

K Xu, E Bastia, M Schwarzschild - Pharmacology & therapeutics, 2005 - Elsevier
In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A2A
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

Therapeutic potential of adenosine A (2A) receptor antagonists in Parkinson's disease

K Xu, E Bastia, M Schwarzschild - Pharmacology & …, 2005 - pubmed.ncbi.nlm.nih.gov
In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A (2A)
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

[引用][C] THERAPEUTIC POTENTIAL OF ADENOSINE A (2A) RECEPTOR ANTAGONISTS IN PARKINSONS DISEASE

K XU, E BASTIA, MA SCHWARZSCHILD - 2005 - sid.ir

Therapeutic potential of adenosine A (2A) receptor antagonists in Parkinson's disease.

K Xu, E Bastia, M Schwarzschild - Pharmacology & Therapeutics, 2004 - europepmc.org
In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A (2A)
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

[引用][C] Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease

K Xu, E Bastia, M Schwarzschild - Pharmacology & Therapeutics, 2005 - cir.nii.ac.jp
Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease

K Xu, E Bastia, M Schwarzschild - Pharmacology and Therapeutics, 2005 - infona.pl
In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A 2A
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease

K Xu, E Bastia, M Schwarzschild - Pharmacology and Therapeutics, 2005 - infona.pl
In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A 2A
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

[引用][C] THERAPEUTIC POTENTIAL OF ADENOSINE A (2A) RECEPTOR ANTAGONISTS IN PARKINSONS DISEASE

K XU, E BASTIA, MA SCHWARZSCHILD - 2005 - sid.ir

[引用][C] Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease

KUI XU, E BASTIA, M SCHWARZSCHILD - Pharmacology & therapeutics, 2005 - Elsevier